Analystreport

Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

Lexicon Pharmaceuticals, Inc.  (LXRX) 
Last lexicon pharmaceuticals, inc. earnings: 4/27 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: lexpharma.com/investors